Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Talk:Trazodone: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
>Maethor1337
add summary/substancebox -- they don't exist yet
>I hate drugs
m expansion of page
 
(4 intermediate revisions by 3 users not shown)
Line 4: Line 4:
{{SubstanceBox/Trazodone}}
{{SubstanceBox/Trazodone}}


'''Trazodone''', first sold as '''Oleptro''', is an antidepresant of the [[Serotonin#Antagonists|serotonin antagonist]] and [[reuptake inhibitor]] (SARI) class, approved as a prescription medicine for major depressive disorder in adults. Trazodone has [[mCPP|''meta''-Chlorophenylpiperazine]] or  [[mCPP|"chlorophenylpiperazine"]] as an active metabolite that contributes to trazodone's pharmacology. <ref> 1-m-Chlorophenylpiperazine is an active metabolite common to the psychotropic drugs trazodone, etoperidone and mepiprazole | http://onlinelibrary.wiley.com/doi/10.1111/j.2042-7158.1982.tb04701.x/abstract;jsessionid=9006CB66248FC2F30E99D5AEAB847661.f04t01</ref>
'''Trazodone''', first sold as '''Oleptro''', is an antidepresant of the [[Serotonin#Antagonists|serotonin antagonist]] and [[reuptake inhibitor]] (SARI) class, approved as a prescription medicine for major depressive disorder in adults. Trazodone produces [[mCPP|''meta''-Chlorophenylpiperazine]] ([[mCPP|"chlorophenylpiperazine"]]) as an active metabolite; it contributes to trazodone's pharmacology. <ref> 1-m-Chlorophenylpiperazine is an active metabolite common to the psychotropic drugs trazodone, etoperidone and mepiprazole | http://onlinelibrary.wiley.com/doi/10.1111/j.2042-7158.1982.tb04701.x/abstract;jsessionid=9006CB66248FC2F30E99D5AEAB847661.f04t01</ref> While it is largely marketed as an antidepressant, nowadays it's often prescribed off label at lower doses <100mg for treating insomnia due to its strong sedative effects. Systematic reviews indicate that low-dose trazodone effectively improves sleep quality in both primary and secondary insomnia, including cases associated with depression. Common side effects include drowsiness, dizziness, dry mouth, and, at higher doses, potential for orthostatic hypotension. <ref> Tradozone prescriptions against insomnia surpass those against depression | https://go.drugbank.com/articles/A181183</ref> At higher doses <150-300mg it shows similar efficacy to other antidepressants. <ref> Trazodone's effectiveness is comparable to other antidepressants | https://annals-general-psychiatry.biomedcentral.com/articles/10.1186/s12991-023-00465-y</ref>
[[File:Trazodone (mCPP moiety labelled).svg|300px|thumbnail|right|Trazodone. Notice the [[mCPP]] moiety.]]
[[File:Trazodone (mCPP moiety labelled).svg|300px|thumbnail|right|Trazodone. Notice the [[mCPP]] moiety.]]


==External links==
==External links==
*[[wikipedia:Trazodone|Trazodone (Wikipedia)]]
*[[wikipedia:Trazodone|Trazodone (Wikipedia)]]
*[https://erowid.org/trazodone/trazodone.shtml Trazodone (Erowid Vault)]
*[https://www.erowid.org/pharms/trazodone/trazodone.shtml Trazodone (Erowid Vault)]
 
==Discussion==


==References==
==References==


[[Category:Approval]]
==Discussion==
[[Category:Proofread]]

Latest revision as of 17:46, 7 December 2024


Summary sheet: Trazodone
Trazodone
Chemical Nomenclature
Common names Trazodone
Substitutive name Desyrel, Molipaxin, Oleptro, Trazorel, Trittico
Class Membership
Psychoactive class Sedative, Antidepressant
Chemical class Triazolopyridine, phenylpiperazine
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



Oral
Dosage
Threshold x - x mg
Light x - x mg
Common x - x mg
Strong x - x mg
Heavy x - x mg
Duration
Total x hours
Onset 1 hour









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.


Trazodone, first sold as Oleptro, is an antidepresant of the serotonin antagonist and reuptake inhibitor (SARI) class, approved as a prescription medicine for major depressive disorder in adults. Trazodone produces meta-Chlorophenylpiperazine ("chlorophenylpiperazine") as an active metabolite; it contributes to trazodone's pharmacology. [1] While it is largely marketed as an antidepressant, nowadays it's often prescribed off label at lower doses <100mg for treating insomnia due to its strong sedative effects. Systematic reviews indicate that low-dose trazodone effectively improves sleep quality in both primary and secondary insomnia, including cases associated with depression. Common side effects include drowsiness, dizziness, dry mouth, and, at higher doses, potential for orthostatic hypotension. [2] At higher doses <150-300mg it shows similar efficacy to other antidepressants. [3]

Trazodone. Notice the mCPP moiety.

Discussion

References

  1. 1-m-Chlorophenylpiperazine is an active metabolite common to the psychotropic drugs trazodone, etoperidone and mepiprazole | http://onlinelibrary.wiley.com/doi/10.1111/j.2042-7158.1982.tb04701.x/abstract;jsessionid=9006CB66248FC2F30E99D5AEAB847661.f04t01
  2. Tradozone prescriptions against insomnia surpass those against depression | https://go.drugbank.com/articles/A181183
  3. Trazodone's effectiveness is comparable to other antidepressants | https://annals-general-psychiatry.biomedcentral.com/articles/10.1186/s12991-023-00465-y